ID

32182

Description

An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT01009047

Link

https://clinicaltrials.gov/show/NCT01009047

Keywords

Versions (1)
  1. 10/23/18 10/23/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

October 23, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Schizophrenia NCT01009047

English

Eligibility Schizophrenia NCT01009047

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
participants must currently meet the diagnostic and statistical manual of mental disorders fourth edition (dsm-iv) criteria for schizophrenia and have experienced symptoms of the illness for at least 1 year, and they should have had at least treatment with 1 antipsychotic before participation in this study
Description

Schizophrenia | Symptoms Schizophrenia Duration | Antipsychotic Agents Quantity

Data type

boolean

Alias
UMLS CUI [1]
C0036341
UMLS CUI [2,1]
C1457887
UMLS CUI [2,2]
C0036341
UMLS CUI [2,3]
C0449238
UMLS CUI [3,1]
C0040615
UMLS CUI [3,2]
C1265611
participants having a positive and negative syndromes scale (panss) score between 60 and 120 inclusive at screening
Description

Positive and Negative Syndrome Scale Clinical Classification

Data type

boolean

Alias
UMLS CUI [1]
C4086747
female participants must be incapable of pregnancy, or if heterosexually active and capable of pregnancy, have been using an acceptable method of contraception for at least 1 month before study entry and agree to continue use contraception methods for the duration of the study, or if sexually abstinent (not having sexual intercourse) and capable of pregnancy, must agree to continue abstinence or to use an acceptable method of birth control
Description

Gender Infertility | Childbearing Potential Sexually active Contraceptive methods | Childbearing Potential Sexual Abstinence | Childbearing Potential Sexual Abstinence Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0021359
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0241028
UMLS CUI [2,3]
C0700589
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0036899
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0036899
UMLS CUI [4,3]
C0700589
participants must not be a danger to themselves or others, and must have family support available to be maintained as out-patients
Description

DANGER OF HARM TO SELF Absent | At risk of harming others Absent | Family support Available

Data type

boolean

Alias
UMLS CUI [1,1]
C0149660
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C1271966
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0150232
UMLS CUI [3,2]
C0470187
participants with a weight of equal to or greater than 29 kilogram
Description

Body Weight

Data type

boolean

Alias
UMLS CUI [1]
C0005910
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
participants with mild (not serious), moderate (medium level of seriousness), or severe (very serious, life threatening) mental retardation
Description

Mild Mental Retardation | Moderate mental retardation | Severe mental retardation | Mental Retardation Life Threatening

Data type

boolean

Alias
UMLS CUI [1]
C0026106
UMLS CUI [2]
C0026351
UMLS CUI [3]
C0036857
UMLS CUI [4,1]
C0025362
UMLS CUI [4,2]
C2826244
participants with a known or suspected history of substance dependence (including alcohol, but excluding nicotine or caffeine) as per the dsm-iv criteria in the 3 months before screening
Description

Substance Dependence | Substance Dependence Suspected | Exception Nicotine Dependence | Exception Caffeine dependence

Data type

boolean

Alias
UMLS CUI [1]
C0038580
UMLS CUI [2,1]
C0038580
UMLS CUI [2,2]
C0750491
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0028043
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1386553
participants with a history of certain neurological (pertaining to the nervous system) disorders or insulin-dependent diabetes mellitus (disorder in which there is decreased insulin in the body or the body's insulin is not effective, resulting in high blood sugar, increased thirst and urine, and many other side effects)
Description

Nervous system disorder | Diabetes Mellitus, Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2]
C0011854
participants who have received a depot injectable antipsychotic within 2 treatment cycles before the screening visit
Description

Injection of depot antipsychotic agent | Treatment Course Quantity

Data type

boolean

Alias
UMLS CUI [1]
C2585377
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0750729
UMLS CUI [2,3]
C1265611
participants who have received clozapine in 2 months before the baseline visit (day 1 of week 1)
Description

Clozapine

Data type

boolean

Alias
UMLS CUI [1]
C0009079
Back to the top of the page

Similar models

Eligibility Schizophrenia NCT01009047

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Schizophrenia | Symptoms Schizophrenia Duration | Antipsychotic Agents Quantity
Item
participants must currently meet the diagnostic and statistical manual of mental disorders fourth edition (dsm-iv) criteria for schizophrenia and have experienced symptoms of the illness for at least 1 year, and they should have had at least treatment with 1 antipsychotic before participation in this study
boolean
C0036341 (UMLS CUI [1])
C1457887 (UMLS CUI [2,1])
C0036341 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0040615 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Positive and Negative Syndrome Scale Clinical Classification
Item
participants having a positive and negative syndromes scale (panss) score between 60 and 120 inclusive at screening
boolean
C4086747 (UMLS CUI [1])
Gender Infertility | Childbearing Potential Sexually active Contraceptive methods | Childbearing Potential Sexual Abstinence | Childbearing Potential Sexual Abstinence Contraceptive methods
Item
female participants must be incapable of pregnancy, or if heterosexually active and capable of pregnancy, have been using an acceptable method of contraception for at least 1 month before study entry and agree to continue use contraception methods for the duration of the study, or if sexually abstinent (not having sexual intercourse) and capable of pregnancy, must agree to continue abstinence or to use an acceptable method of birth control
boolean
C0079399 (UMLS CUI [1,1])
C0021359 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0241028 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,3])
C3831118 (UMLS CUI [3,1])
C0036899 (UMLS CUI [3,2])
C3831118 (UMLS CUI [4,1])
C0036899 (UMLS CUI [4,2])
C0700589 (UMLS CUI [4,3])
DANGER OF HARM TO SELF Absent | At risk of harming others Absent | Family support Available
Item
participants must not be a danger to themselves or others, and must have family support available to be maintained as out-patients
boolean
C0149660 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1271966 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0150232 (UMLS CUI [3,1])
C0470187 (UMLS CUI [3,2])
Body Weight
Item
participants with a weight of equal to or greater than 29 kilogram
boolean
C0005910 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Mild Mental Retardation | Moderate mental retardation | Severe mental retardation | Mental Retardation Life Threatening
Item
participants with mild (not serious), moderate (medium level of seriousness), or severe (very serious, life threatening) mental retardation
boolean
C0026106 (UMLS CUI [1])
C0026351 (UMLS CUI [2])
C0036857 (UMLS CUI [3])
C0025362 (UMLS CUI [4,1])
C2826244 (UMLS CUI [4,2])
Substance Dependence | Substance Dependence Suspected | Exception Nicotine Dependence | Exception Caffeine dependence
Item
participants with a known or suspected history of substance dependence (including alcohol, but excluding nicotine or caffeine) as per the dsm-iv criteria in the 3 months before screening
boolean
C0038580 (UMLS CUI [1])
C0038580 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0028043 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1386553 (UMLS CUI [4,2])
Nervous system disorder | Diabetes Mellitus, Insulin-Dependent
Item
participants with a history of certain neurological (pertaining to the nervous system) disorders or insulin-dependent diabetes mellitus (disorder in which there is decreased insulin in the body or the body's insulin is not effective, resulting in high blood sugar, increased thirst and urine, and many other side effects)
boolean
C0027765 (UMLS CUI [1])
C0011854 (UMLS CUI [2])
Injection of depot antipsychotic agent | Treatment Course Quantity
Item
participants who have received a depot injectable antipsychotic within 2 treatment cycles before the screening visit
boolean
C2585377 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0750729 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Clozapine
Item
participants who have received clozapine in 2 months before the baseline visit (day 1 of week 1)
boolean
C0009079 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial